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Abstract 
Introduction 
Early diagnosis and treatment of cancer is the goal of the two-week wait referral pathway 
(2WW). Variation exists between General Practice use of 2WW and rates of consultant 
reprioritisation of GP referral from routine to 2WW (Consultant Upgrade). We investigated 
variation in General Practice and Consultant Upgrade 2WW referral activity. 
 
Methods 
Data from 185,000 referrals and 29,000 cancers recorded between 2011-13 from the 
Northern Ireland Cancer Waiting Time database (CAPPS) were analysed to ascertain 
standardised referral rate ratios, detection rate (DR) [=sensitivity] and conversion rate (CR) 
[=positive predictive value] for Practice 2WW referrals and Consultant Upgrade 2WW. 
Metrics were compared using Spearman’s rank correlation co-efficients. 
 
Results 
There was consistency in Practice and Consultant Upgrade 2WW referral rates over time, 
though not for annual DR (Spearman’s ρ<0.37) or CR (Spearman’s ρ<0.26). Practice 2WW 
referral rates correlated negatively with CR and positively with DR while correlations 
between DR and CR were restricted to single year comparisons in Practice 2WW. In 
Consultant Upgrade 2WW CR and DR were strongly correlated but only when the same 
cancers were included in both rates. 
 
Conclusion 
Results suggest ‘random case mix’ explains previously reported associations between CR 
and DR with more ‘hard to detect’ cancers in some Practices than in others in a given year 
corresponding to lower DR and CR. Use of Practice and Consultant Upgrade 2WW referral 
metrics to gauge General Practice performance may be misleading. 
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Introduction 
Earlier diagnosis and treatment of cancer is a crucial step towards improved cancer survival 
(Richards, 2009). Therefore, considerable resources and research effort are directed toward 
identifying and eliminating the causes of delay in a patient’s pathway to diagnosis. Several 
studies have attributed a significant proportion of the time from symptom onset to diagnosis 
and treatment to General Practice (Lyratzopoulos et al, 2015; Allgar & Neal, 2005; Rikke et 
al, 2011) and secondary care delays (Jensen et al, 2014). 
 
In the UK, an urgent General Practice referral system was established whereby a referral for 
suspected cancer triggers priority investigation with the aim that cases of suspected cancer 
should be investigated within two weeks of referral. In addition, consultants in secondary 
care can upgrade routine symptomatic referrals to 2WW (the two week wait referral 
pathway) or downgrade 2WW to routine referral status. In Northern Ireland (NI), current 
targets require Health & Social Care Trusts to commence treatment of at least 95% of such 
referred patients within 62 days of referral (National Health Service, 2000). Targets are also 
in place for all urgent suspected breast cancer patients to have a first assessment by a 
breast cancer specialist within 14 days of referral. Trusts are also mandated to treat at least 
98% of all cancer patients within 31 days of a decision to treat. However, there are no 
specific targets in place to expedite investigation and diagnosis of routinely referred cancer 
patients in secondary care (Department of Health Northern Ireland, 2015). 
 
The choice of cancer referral route is an important predictor of delay in the UK (Larsen et al, 
2013; Jensen et al, 2014). Concern exists that inappropriate non-urgent referral by General 
Practitioners of patients subsequently proven to have cancer may contribute to diagnostic 
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delays (Baughan et al, 2009). Variation in the rate and accuracy of the 2WW system in 
General Practice exists. This has been taken to indicate inconsistency in referral guideline 
application by GPs, suggesting potential opportunities for improvement (Howell et al, 2013; 
McCoubrey et al, 2012; Meechan et al, 2012). Understanding this variation has the potential 
to illuminate the quality of patient care.  
 
In addition to Practice 2WW referrals, upgrades of routine Practice referrals by consultants in 
secondary care account for a significant proportion of the total volume of 2WW referrals 
(South Eastern Health & Social Care Trust, 2014) and the total volume of cancers detected 
via the 2WW (Bannon et al, 2014; Cairnduff et al, 2016). Because these consultant upgrades 
(CU) aim to provide a failsafe mechanism to ensure appropriate fast tracking of suspected 
cancers not identified by the general practitioners, they may provide insights into referral 
quality in General Practice as upgrades reflect a variation between Practice and consultant 
appraisal. It may be hypothesised that high rates of Consultant Upgrade 2WW following 
Practice referral may be an indicator of poor General Practice referral decisions and the 
detection of more cancers may highlight poor categorisation of suspected cancer cases in 
General Practice.  
 
A 2012 cross-sectional study of the use of 2WW referrals for all cancer diagnoses in 
England in 2009 (Meechin et al, 2012) reported three main measures of 2WW referral 
activity. 
 
1. The standardised referral rate ratio (SRR), defined as the ratio of observed to 
expected referrals for a practice of a defined size and age-sex population structure;  
2. The conversion rate (CR), defined as the proportion of 2WW referrals that result in 
a cancer diagnosis and is the equivalent to the positive predictive value (PPV) and; 
3. The detection rate (DR), this is the proportion of cancers diagnosed that were 2WW 
referrals and is equivalent to sensitivity. 
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The authors observed significant correlations between the SRR and the CR (negatively 
correlated) and the SRR and the DR (positively correlated) as well as a significant positive 
correlation between the DR and the CR. The positive correlation between DR and CR was 
unexpected due to their contrasting relationship with the SRR. Consequently, this 
relationship was interpreted as a potential indicator of the quality of clinical practice, with 
Practices recording higher CR and DR assumed to be making better referral decisions than 
those with low CR and DR. The results were swiftly included in cancer services policy, and 
Practices in England and Wales were ranked on the basis of their annual DR and CR for 
their use of 2WW referrals. Practice profiles were subsequently published as a measure of 
General Practice performance (Public Health England, 2016). 
 
More recently, a 2015 study by Murchie et al suggested that the use of DR, CR and 2WW 
referral rates as measures of Practice performance fails to account for important differences 
between cancers and for the effect of ‘random case-mix’ – the fact that some cancers are 
easier to diagnose than others. Their analysis of routine data on “urgent-suspected cancer” 
referrals between 2006 and 2013 from the NHS Grampian Cancer Care Pathway database 
suggested random case-mix was apparent in single-year observations due to small samples 
within General Practice, but this was addressed by combining years to increase sample size 
and reduce case-mix variability. In these larger samples of cancer patients in each Practice, 
no association between DR and CR was observed. Despite this, annual Practice Profiles 
continue to be published and publicized in England, and their introduction has been 
proposed elsewhere in the UK. It is therefore important to investigate elsewhere within the 
UK to determine if the findings reported by Murchie et al can be replicated. 
 
This study investigated variation of Practice and Consultant Upgrade 2WW referral profiles 
in a UK region with a view to understanding the role they can play as indicators of care 
quality for cancer diagnosis in General Practice. The results could have implications for 
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cancer services performance measurement in General Practice in the UK and other 
healthcare systems that use similar policies. 
 
Materials and Methods 
Suspected cancer referrals by age, sex and Practice were generated from the region-wide 
Cancer Patient Pathway System (CaPPs) database. The database is an administrative 
system used by multi-disciplinary teams in secondary care to manage suspected cancer 
patients and is also used to monitor compliance with cancer waiting time targets in NI 
(Northern Ireland Assembly, 2011).  
 
Inclusion criteria 
The database for the study included all referrals for suspected cancer, at any site, recorded 
on CaPPS between 1 January 2011 and 31 December 2013 for all General Practices in 
Northern Ireland. 
 
Exclusion criteria 
Duplicate records were omitted from the study. These included records with the same Health 
and Care Number (a unique identifier), date of referral and referral priority. Records with 
unknown referral priority or unknown Practice were also excluded.  
 
Statistical analysis  
An anonymised extract of the CaPPS database was loaded into Stata 11.2 (StataCorp, 
2011) to generate the study database. Individual General Practitioner codes were identified 
for each patient using Practice Cipher numbers and where these were unrecorded, they 
were manually identified using the HSC Webview system in the secure environment of the 
NICR.  
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The primary unit of analysis in the study was General Practice. The key measures in the 
study were the SRR, DR and CR. These measures are outlined below. These were 
calculated for both Practice 2WW referrals and for Consultant Upgrade 2WW referrals. 
 
Standardised Referral Rate Ratio (SRR) was calculated using indirect age-sex 
standardisation. Demographic profiles (recorded in July of each year) by 5-year age-sex 
bands for each Practice in NI from HSC Business Services Organisation were used to 
calculate expected referrals in each Practice. The SRR was calculated as a comparison of 
the expected number of referrals against the observed number of referrals for each Practice.  
 
Conversion Rate (CR) 
CR was defined as the proportion of 2WW referrals that had a subsequent cancer diagnosis 
recorded in CaPPS on either the 31 or 62-day patient pathway. These were calculated for 
each year and for each General Practice for the four most common suspected non-skin 
cancer sites (urology (C60-C68), lower GI (C18-C21), lung cancer (C33 & C34) and female 
breast cancer (C50)) as well as for all suspected cancers combined. 
 
Detection Rate (DR) 
DR was defined as the proportion of cancers that were detected in the 2WW pathway out of 
all the cancers diagnosed in that Practice population. These were also produced for the four 
most common suspected non-skin cancer sites as well as for all suspected cancers 
combined. For Consultant Upgrade 2WW referrals, sensitivity analysis was undertaken 
calculating DR excluding cancers from the denominator already referred via the 2WW.  
 
Funnel plots (Spiegelhalter, 2002) were used to present Practice variation in the SRR for 
each year and all years combined with control limits set at three standard deviations. To 
investigate the relationship between 2WW SRR, CR and DR, Spearman’s rank correlation 
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coefficients were produced for each year and all years combined for all cancers for both 
Consultant Upgrade and Practice 2WW referrals.  
 
Sensitivity analysis 
Sensitivity analysis was undertaken to investigate if any associations between CR and DR 
were due to the fact that both metrics were derived from the same small number of events in 
each Practice rather than differences in referral behaviour between practices This was 
undertaken by comparing CR and DR in different years to ensure that the same cancer 
cases are not included in the two metrics.  
 
Results 
There were 353 Practices in NI during the period 2011 to 2013. The median patient list size 
of these Practices was 4,814 in 2011 with an inter-quartile range of 1,700, the smallest 
Practice had fewer than 1,300 patients and the largest had almost 15,000. 
 
Following exclusion of duplicate and error records (n=62,472), there were 188,337 records 
of referral on the CaPPS database from 2011-13 with 28,725 confirmed cancers recorded. 
There were 85,721 registered as 2WW referrals from a Practice and these were associated 
with 10,846 confirmed cancers with a median of 195 referrals and 23 cancers diagnosed in 
each practice annually. After exclusion of 1,037 2WW referrals that were not attributed to 
any Practice there were 84,684 2WW referrals and 28,443 cancers recorded across the 353 
Practices in NI (see Figure 1). 
 
Patterns in referral, DR and CR varied significantly by Practice. Funnel plots for Practice and 
Consultant Upgrade 2WW referral rates are presented in a supplementary figure. Practice 
and Consultant Upgrade Variation differed by suspected tumour type and was lower for 
suspected lung cancer whilst being higher for suspected breast, lower GI and urological 
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cancers (see Table 1). Median DR and CR by practice were higher for Practice 2WW 
referrals than for Consultant Upgrade 2WW referrals with marked variation for both 
Consultant Upgrade and Practice 2WW referrals and variation by disease location. 
Specifically, Practice conversion rates were highest for lung cancer, detection rates were 
highest for breast while lower GI was lowest for both. Only among urological referrals did 
median conversion rates from consultant upgrades exceed 10% (see Table 1). 
 
To determine if referral practices among General Practices were consistent over time, 
annual Practice ranking of their SRR were compared using Spearman’s rank correlation 
coefficient. There was a strongly positive correlation in the SRR for both Consultant Upgrade 
and Practice 2WW referrals. The same analysis was applied to annual DR and CR. Unlike 
referral rates, the correlation between annual Practice CR and DR were weak for both 
Consultant Upgrade and Practice 2WW referrals (see Table 2). 
 
The relationship between SRR, CR and DR 
All cancers 
Scatter plots and Spearman’s rank correlation coefficients were used to compare the three 
metrics. Practice SRR ratios were positively correlated with DR and negatively with CR. This 
relationship was consistently observed each year and for all years combined (see Table 3). 
Like Practice 2WW referrals, Consultant Upgrade 2WW rates were positively correlated with 
DR, though, the correlation between SRR and CR observed for Practice referrals was not 
observed for Consultant Upgrade referrals. 
 
Regarding the relationship between CR and DR, Figure 2 illustrates how the relationship 
between Practice CR and DR, apparent for a single year comparison, diminish when all 
years are combined. In contrast, for Consultant Upgrade referrals, a strong association 
between CR and DR was observed in the full dataset as well as the single year 
comparisons. 
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By cancer site 
Similar correlations were observed by cancer site as for all cancers combined, though there 
was no negative association between SRR and CR for lung cancer.  The same patterns 
were observed for Consultant Upgrade referrals though a weak positive correlation between 
SRR and CR was observed for suspected female breast and lower GI cancers (see Table 4). 
 
Sensitivity analysis 
To assess the role of case-mix confounding in explaining the relationship between CR and 
DR, they were compared for different years, thereby separating the cancer cases included in 
the two metrics. Any correlations observed would therefore be more likely due to the referral 
practices rather than the random case-mix of disease characteristics. The results of these 
comparisons are presented in a supplementary table. There was no evidence of significant 
correlation between CR and DR except for those calculated for the same year, which include 
the same cancer case mix in both metrics. 
 
Discussion 
The 2WW referral system has been in place in the UK since 2000 (National Health Service, 
2000). While there has been variation in Practice referral patterns reported since the 
establishment of the system, few studies have investigated robustly this variation including 
potentially attributable quality indicators. This study improves our understanding of variation 
in use of the 2WW referral system in Practice and, in the context of previous studies, 
indicates the extent to which measures of General Practice and Consultant Upgrade 2WW 
referral, CR and DR may be used as a measure of practitioner performance with a view to 
identifying and spreading best practice.  
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Key findings 
Variation in Practice and Consultant Upgrade SRRs was highly dispersed and variation was 
unexplained by age and sex distribution of patient populations. Similar to previous studies 
Meechin et al, 2012; Murchie et al, 2015), Practice referral rates correlated positively with 
DR and negatively with CR. Lower referral rates suggested the application of a higher 
threshold for suspicion before referral and hence higher predictive power (CR) and lower 
sensitivity (DR), while a higher referral rate was suggestive of a lower threshold of suspicion 
before referral and consequently lower predictive power and higher sensitivity. There was 
also significant variation by disease site with particularly low CR and DR for lower GI 
cancers reflecting the low predictive power of its symptoms. 
 
DR and CR as performance metrics 
Consistent with Murchie et al (2015), the positive relationship between CR and DR, 
previously suggested by Meechin et al (2012) as a quality indicator for referral, was 
observed in the analysis of single-year data but was not apparent when comparing several 
years combined. This pattern may be explained by a combination of small numbers of 
cancer cases in each Practice and case-mix and, specifically, the ease with which a cancer 
is diagnosed. A Practice with a group of more easily diagnosed patients one year will have 
both higher CR and higher DR; similarly, the same Practice in another year may have a 
larger number of more difficult to diagnose cancers and consequently have both low DR and 
CR. As these rates are derived from the same events, they correlate, particularly at a 
Practice level where there are few cases of cancer diagnosed annually. So while studies 
using very large administrative datasets of cancer referrals may appear statistically robust, 
the units of comparison are dependent upon a small number of cancers in each Practice 
where comparisons are sensitive to case-mix confounding. We therefore require a number of 
years to accumulate a sufficient number of cancer records to address this case-mix 
confounding. Murchie et al (2015) used simulation modelling to estimate that approximately 
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25 cancers must be observed in a Practice to address this case-mix. In this study the 
average annual number of cancers in each General Practice was 23, with an average of 80 
over the three-year period. The absence of correlation in the larger 3-year dataset suggests 
that these relationships may be explained by case-mix rather than by the quality of referral 
activity. Although correlation between CR and DR was observed over the entire study period 
for individual cancer sites, this pattern was also likely to be related to a small number of 
cancers in General Practices over the study period. General Practice comparisons of referral 
rates for even the most common cancers may require up to a ten-year period to accrue a 
sufficient number of cancers in each practice and overcome case-mix influences. 
 
Consultant upgrade activity as indicators of performance 
Consultant Upgrade 2WW referrals showed a strong correlation between CR and DR 
including over a three year period, though it was only apparent when comparing CR and DR 
from the same years and was not observed when CR for one year was compared with the 
DR of another year. This finding may suggest that the observed correlations occurred 
because the variables are bonded by the same handful of cancer patients in each Practice 
and the specific characteristics of these cancers rather than because of the quality of the 
referral behaviour in General Practices. The suggestion that measures of referral rate activity 
may be used as quality indicators assumes that there is temporal consistency in the 
characteristics of General Practice referral activity over time. While there appeared to be a 
strong relationship in the referral rates over time, there was no evidence to suggest any 
temporal consistency in CR or DR. Again, this analysis suggests case-mix variation has a 
significant bearing on these measures, with no evidence to suggest that the CR or DR in a 
Practice in any one year could be predictive of those in successive years. The evidence here 
strongly suggests that use of CR and DR as quality indicators for Practice referral is 
methodologically weak and that several years of referrals are required to gather robust 
evidence of General Practice referral activity and to determine if there is any temporal 
consistency when case mix confounding is addressed.  
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Overall CR and DR were lower for Consultant Upgrade referrals compared to Practice 
referrals, the lower CR and DR among Consultant Upgrade referrals may reflect the fact that 
consultants were selecting from patients previously screened in General Practice who had 
already identified the more easily diagnosed cancers leaving only the ‘margin calls’ with a 
low index of suspicion to be identified by the Consultants. This clearly highlights that even 
with expert opinion the clinical diagnosis of cancer will involve the investigation of large 
patient volumes for every patient diagnosed due to the low predictive power of symptoms 
rather than GP decision-making. 
  
Strengths and weaknesses 
This study enhances our understanding about variation in referral metrics in General 
Practice in a UK region using a regional database that includes referrals from all General 
Practices. The inclusion of three years of referral data enabled investigation of the risk of 
misinterpreting results due to case-mix confounding and analysis of temporal trends in 
referral metrics. Moreover, temporal separation of CR and DR help us understand the limited 
role that Practice CR and DR can have as measures of quality of cancer care. It is 
noteworthy, however, that the main findings here were observed previously in Scotland 
(Murchie et al, 2015) and NI where average Practice list size almost 20% smaller than 
compared to England and Wales (Health & Social Care Information Centre, 2015). 
Consequently, the average number of cancers diagnosed in General Practice is also lower 
(Public Health England, 2016). While the longer time period for accrual of cancer patients 
ensured sufficiently large samples, it would still be useful to confirm these findings 
elsewhere. 
 
Implications 
This study investigated the validity of a measure of referral quality that has been widely 
reported in England (Public Health England, 2016). This study, with large General Practice 
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samples, provided no evidence to support the application of such quality metrics and 
suggests these performance measures misinform service users and stakeholders.  We 
require a much better understanding of the 2WW referral system and its implication for 
practitioner behaviour and for patient outcomes on a population level before developing 
measures of General Practice performance for cancer referral.  Given the relationship with 
DR, standardised referral rate ratios should not be ignored as a potentially useful indicator of 
quality, although their relationship with patient outcomes requires further investigation. While 
this study dispelled the suggestion of a consistent pattern in CR and DR, it also identified 
groups of General Practices in the 3-year cohort that had both high DR and CR and other 
groups with both low CR and DR. There is a need to understand whether these groups can 
identify General Practices with better and worse referral practices and if these have a 
relationship with patient outcomes. In particular, further research is necessary to determine 
the extent to which this variation may be explained by access to and use of diagnostic tools 
such as chest x-ray to diagnose lung cancer and PSA testing in the profiling of patients with 
symptoms of prostate cancer. Previous studies have examined the extent to which variation 
in chest x-ray rates among General Practices were associated with stage and mortality 
(O’Dowd et al, 2015), similarly, studies of General Practice variation of PSA testing have 
examined their role in cancer mortality and incidence (Hjertholm et al, 2015). However, it 
may be hypothesised that Practices with higher usage of these diagnostic tools may be more 
accurate in their referrals, hence improving risk profiling of patients, expediting diagnosis and 
reducing burden on secondary care. Further work ought to be undertaken to investigate if 
these Consultant Upgrade and Practice referral metrics are associated with cancer mortality 
and survival. 
 
The significant variation in 2WW SRR, CR and DR by disease site also reinforces the view 
that a one size fits all system for referral of suspected cancer in General Practice is 
inappropriate. The detection rates of less than 25% and conversion rates of less than 5% 
ensure that the 95% of patients referred on the 2WW system who are not subsequently 
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diagnosed with cancer are prioritised ahead of over 75% of the cancer patients who were not 
referred via this route. This has the potential to lead to the unintended consequence of 
delaying diagnosis of cancer patients. On balance, lower GI cancer patients may be better 
served by a higher diagnostic threshold for 2WW referral and associated waiting time targets 
for 2WW routine referral. Further research examining waiting times for both routine and 
2WW referrals is required to inform policies and targets for these harder to diagnose cancer 
types. 
 
 
Conclusion 
There is a current desire to produce measures of General Practice activity that can be used 
to influence practitioner behaviour with a view to improving cancer outcomes through earlier 
diagnosis. Given that most cancers are diagnosed clinically in primary care (Elliss-Brookes 
et al, 2012), this should be a policy area with potential to improve outcomes. However, the 
relatively few cancers diagnosed by any individual Practitioner each year not only presents 
challenges to practitioners in identifying the cancer patient who is a ‘needle in the haystack’ 
but also to statisticians and researchers who must attempt to find meaning in data which 
deals with what are relatively rare events even for the most common cancers. Current use of 
Practice and Consultant Upgrade referral rate metrics as measures of General Practice 
performance is inappropriate and ought not to be considered due to case-mix confounding. 
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